SCHEMBL4757296

SCHEMBL4757296

CCC(CC)S(=O)(=O)c1csc(NC(=O)c2ccc(C)cc2OC(C)=O)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
MITF O75030 1/20 0.40
RXFP1 Q9HBX9 1/20 0.37
GCK P35557 4/20 0.37
SORT1 Q99523 1/20 0.36
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
HTT P42858 3/20 0.35
ALDH1A1 P00352 3/20 0.35
MAPT P10636 3/20 0.35
POLB P06746 1/20 0.35
MAPK1 P28482 1/20 0.35
GAA P10253 2/20 0.35
HSD17B10 Q99714 2/20 0.35
LMNA P02545 2/20 0.35
PKM P14618 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4757060 0.92 GCK (0.37) KDM4ENPC1RAB9ASMN1; SMN2MITF
SCHEMBL10114598 0.90 KDM4E (0.41) KDM4ENPC1RAB9ASMN1; SMN2MITF
SCHEMBL4931674 0.85 GCK (0.41) KDM4ENPC1RAB9ASMN1; SMN2RXFP1
SCHEMBL12974190 0.78 GCK (0.41) KDM4ENPC1RAB9ASMN1; SMN2MITF
SCHEMBL12994105 0.76 ALDH1A1 (0.47) KDM4ENPC1RAB9ASMN1; SMN2MITF
SCHEMBL12974198 0.74 ALDH1A1 (0.48) KDM4ENPC1RAB9ASMN1; SMN2MITF
SCHEMBL4756830 0.73 ABL1 (0.38) KDM4ENPC1RAB9ASMN1; SMN2MITF
SCHEMBL703188 0.72 ALDH1A1 (0.50) KDM4ENPC1RAB9ASMN1; SMN2MITF
SCHEMBL4757291 0.70 NPC1 (0.49) KDM4ENPC1RAB9ASMN1; SMN2GCK
SCHEMBL10114719 0.70 KDM4E (0.39) KDM4ENPC1RAB9ASMN1; SMN2MITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC KDM4E 2428/4885NPC1 585/4885RAB9A 1694/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.